Shares of Unilife Corporation (NASDAQ:UNIS) Drops by -21.02%
Unilife Corporation (NASDAQ:UNIS) has lost 21.02% during the past week and dropped 28.35% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 20.02%. Unilife Corporation (NASDAQ:UNIS) has underperformed the index by 28.38% in the last 4 weeks. Investors should watch out for further signals and trade with caution.
Unilife Corporation has dropped 57.49% during the last 3-month period . Year-to-Date the stock performance stands at -58.51%. The company shares have dropped 40.09% in the past 52 Weeks. On January 27, 2015 The shares registered one year high of $4.9 and one year low was seen on August 6, 2015 at $1.15. The 50-day moving average is $1.95 and the 200 day moving average is recorded at $3.15. S&P 500 has rallied 7.26% during the last 52-weeks.
The company has received recommendation from many analysts. 4 analysts have rated the company as a strong buy. 2 analysts have suggested buy for the company.
On a different note, The Company has disclosed insider buying and selling activities to the Securities Exchange, The officer (See Remarks), of Unilife Corp, Pyers Dennis had unloaded 17,349 shares at $3.08 per share in a transaction on May 14, 2015. The total value of transaction was $53,435. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
Shares of Unilife Corporation (NASDAQ:UNIS) ended Friday session in red amid volatile trading. The shares closed down 0.06 points or 4.14% at $1.39 with 1,442,652 shares getting traded. Post opening the session at $1.39, the shares hit an intraday low of $1.37 and an intraday high of $1.45 and the price vacillated in this range throughout the day. The company has a market cap of $182 million and the number of outstanding shares have been calculated to be 131,215,000 shares. The 52-week high of Unilife Corporation (NASDAQ:UNIS) is $4.9 and the 52-week low is $1.15.
Unilife Corporation (Unilife) is a developer, manufacturer and supplier of injectable drugs delivery systems. The Company manufactures and supplies its devices to pharmaceutical companies in a format where they can be filled and packaged with an injectable therapy prior to its shipment to the end-user. The Companys technology platforms cover six device categories: Prefilled Syringes, Drug Reconstitution Delivery Systems, Auto-Injectors, Wearable Injectors, Ocular Delivery Systems and Delivery Systems.
Do your own DD. Anything I post is for entertainment purpose only and should not assist you in any trading decision based on anything I post.
